Clin2
NCT07688746Possibly a fitRecruiting

Helping premature babies heal brain injury

White Matter InjuryBrain Injury, Fetus and NeonateNeonatal Brain InjuryPeriventricular LeukomalaciaPeriventricular White Matter Abnormalities

Treatments studied

Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Injuries & trauma, Women’s health & pregnancy clinical trials.

This trial tests a treatment for brain injury in premature babies born before 32 weeks. It aims to protect and repair white matter, the part of the brain that helps nerve cells communicate.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
24 people
Ages
3 weeks to 5 months
Study type
Interventional

Who can take part

  • Born at or before 32 weeks of pregnancy
  • Between 35 and 41 weeks old since your last period or ultrasound dating
  • Have a brain injury seen on an MRI or ultrasound
  • Currently in a hospital intensive care nursery that is part of the study
  • No major health issues like genetic disorders, recent bleeding in the brain, or other serious conditions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06065670Not yet recruiting· Phase 1/Phase 2
Clemastine for myelin repair in multiple sclerosis

This trial tests if clemastine fumarate, an antihistamine, helps repair myelin (the protective coating around nerves) in people with relapsing-remitting MS. You'd take the drug and have special MRI scans to see if your brain lesions improve.

San Francisco, California
NCT05359653Recruiting· Phase 1/Phase 2
Clemastine to study MRI changes in relapsing MS

This early-phase study tests whether clemastine (a drug being studied for “myelin repair”) changes how MS looks on special MRI scans. It may help researchers understand if the treatment supports restoring nerve covering in people with relapsing-remitting MS.

San Francisco, California
NCT02521311Recruiting· Phase 2
Clemastine to help restore nerve covering in optic neuritis

This Phase 2 trial tests whether clemastine can help regrow the protective covering around the optic nerve after acute optic neuritis (an inflammation-related vision problem). It may help improve vision recovery and signal how well “remyelination” happens.

San Francisco, California
NCT07189494Recruiting
Early brain markers for better outcomes in newborns

This study looks at early brain scans and other markers to help predict and improve outcomes for newborns with brain injuries that might lead to cerebral palsy. It aims to find better ways to identify these high-risk babies early.

Paris
NCT06098833Recruiting· Phase 2
Sildenafil for newborn brain injury after birth asphyxia

This trial tests whether a liquid form of the medicine sildenafil can help repair brain damage in newborns who had a difficult birth and were treated with cooling. If your baby meets the cooling criteria and has brain injury on an MRI, this study may offer an additional treatment option.

Montreal, Quebec
NCT06522581Recruiting· Phase 1
Citicoline for brain injury in newborns

This trial tests if citicoline, a brain-protecting supplement, can help newborns with moderate to severe brain injury from lack of oxygen. It is for babies who have not gotten cooling treatment.

Rawalpindi

Hear when a new Neonatal Brain Injury trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.